Natriuretic peptide testing for predicting adverse events following heart failure hospitalization (Q27008553)

Marc Silver

series ordinal

3

1 reference

Yang Xue

series ordinal

4

1 reference

Christopher DeFilippi

series ordinal

5

1 reference

language of work or name

1 reference

2012

1 reference

published in

Congestive Heart Failure

1 reference

volume

18 Suppl 1

1 reference

page(s)

S9-S13

1 reference

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X

Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7133.2012.00306.X